|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.97 USD | +1.65% |
|
+1.49% | +14.68% |
| Fiscal Period: October | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | - | - | - | - | - | |||||
Gain (Loss) on Sale of Investment, Total (Rev) | -38.48M | - | - | - | - | |||||
Interest And Invest. Income (Rev) | 37.98M | 23.78M | 26.69M | 19.96M | 21.85M | |||||
Total Revenues | -504K | 23.78M | 26.69M | 19.96M | 21.85M | |||||
Gross Profit | -504K | 23.78M | 26.69M | 19.96M | 21.85M | |||||
Selling General & Admin Expenses, Total | 14.3M | 13.09M | 11.17M | 10.95M | 11.12M | |||||
Other Operating Expenses | - | - | - | 78.82K | 66.13K | |||||
Other Operating Expenses, Total | 14.3M | 13.09M | 11.17M | 11.03M | 11.18M | |||||
Operating Income | -14.8M | 10.69M | 15.52M | 8.93M | 10.66M | |||||
Interest Expense, Total | -7.01M | -10.84M | -24.46M | -25.43M | -22.42M | |||||
Net Interest Expenses | -7.01M | -10.84M | -24.46M | -25.43M | -22.42M | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | -24.2M | 6.76M | 3.39M | 1.99M | -752K | |||||
EBT, Excl. Unusual Items | -46.01M | 6.61M | -5.54M | -14.52M | -12.51M | |||||
Gain (Loss) On Sale Of Investments | 363M | -332M | -4.07M | 193M | 198M | |||||
EBT, Incl. Unusual Items | 317M | -326M | -9.61M | 179M | 186M | |||||
Earnings From Continuing Operations | 317M | -326M | -9.61M | 179M | 186M | |||||
Net Income to Company | 317M | -326M | -9.61M | 179M | 186M | |||||
Net Income - (IS) | 317M | -326M | -9.61M | 179M | 186M | |||||
Net Income to Common Incl Extra Items | 317M | -326M | -9.61M | 179M | 186M | |||||
Net Income to Common Excl. Extra Items | 317M | -326M | -9.61M | 179M | 186M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.3 | -4.3 | -0.13 | 2.32 | 2.32 | |||||
Basic EPS - Continuing Operations | 4.3 | -4.3 | -0.13 | 2.32 | 2.32 | |||||
Basic Weighted Average Shares Outstanding | 73.69M | 75.66M | 76.38M | 77.11M | 80.03M | |||||
Net EPS - Diluted | 4.3 | -4.3 | -0.13 | 2.32 | 2.32 | |||||
Diluted EPS - Continuing Operations | 4.3 | -4.3 | -0.13 | 2.32 | 2.32 | |||||
Diluted Weighted Average Shares Outstanding | 73.69M | 75.66M | 76.38M | 77.11M | 80.03M | |||||
Normalized Basic EPS | -0.39 | 0.05 | -0.05 | -0.12 | -0.1 | |||||
Normalized Diluted EPS | -0.39 | 0.05 | -0.05 | -0.12 | -0.1 | |||||
Dividend Per Share | 1.16 | 1.2 | 1.2 | 1.2 | 1.2 | |||||
Payout Ratio | 26.04 | -25.75 | -867.68 | 47.23 | 47.29 | |||||
Supplemental Items | ||||||||||
EBITA | -14.8M | 10.69M | 15.52M | 8.93M | 10.66M | |||||
EBIT | -14.8M | 10.69M | 15.52M | 8.93M | 10.66M | |||||
Total Revenues (As Reported) | -504K | 23.78M | 26.69M | 19.96M | 21.85M | |||||
Normalized Net Income | -28.76M | 4.13M | -3.46M | -9.07M | -7.82M | |||||
Interest on Long-Term Debt | 4.76M | 5.77M | 5.15M | 5.25M | 5.94M | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 14.3M | 13.09M | 11.17M | 10.95M | 11.12M |
Select your edition
All financial news and data tailored to specific country editions
















